This archived issue is not backfilled with observations from a later screening run.
Issue 001 | U.S. Pilot | US
PASW
Ping An Biomedical Co., Ltd.
Screen state: Passing
Source state: Verified
20-F | 2026-01-30
Filing currency: CNY
Internal NCAV Discount
46.1%
GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.
- Current Assets
- 63,697,447CNY
- Total Liabilities
- 23,172,520CNY
- NCAV
- 5,966,480CNY
- Cash
- 1,172,480CNY
- NCAV per share
- 1.98CNY/share
- Evidence
- 1 annual | 5 quarterly
Mary filing review
Financial Statement Evidence
Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.
Business Profile
Published only when a substantive filing-text profile has been prepared for this issue.
Not available for this issue.
A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.
Known Unknowns
Only 5 quarterly periods available from Data Vault for this company.
Medium | Share Count
The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Annual Financials
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-09-30
20-F
CNY
|
|---|---|
| Revenue | 34,147,936 |
| Operating Income | -14,701,471 |
| Net Income | -12,829,206 |
| Cash From Operations | -6,427,762 |
| Capex | n/a |
| Free Cash Flow | n/a |
| Cash And Equivalents | 1,172,480 |
| Accounts Receivable | 16,930,876 |
| Inventory | 441,904 |
| Total Current Assets | 63,697,447 |
| Total Assets | 68,414,527 |
| Total Current Liabilities | 23,076,822 |
| Total Liabilities | 23,172,520 |
| Shareholders Equity | 45,242,007 |
| Shares Outstanding | 20,500,000 |
| Shares Outstanding Diluted | n/a |
| Weighted Avg Shares Diluted | 18,479,452 |
| Weighted Avg Shares Basic | 18,479,452 |
| Net Share Count Change (Normalized) | Insufficient evidence |
| Ownership Claim Change (Normalized) | Insufficient evidence |
Quarterly Financials
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
Only 5 quarterly periods available from Data Vault for this company.
| Metric |
2025-09-30
20-F
CNY
|
2025-09-30
20-F
CNY
|
2025-03-31
6-K
CNY
|
2024-09-30
6-K
CNY
|
2024-03-31
6-K
CNY
|
|---|---|---|---|---|---|
| Revenue | -117,430,017 | -117,430,017 | 18,230,963 | 87,622,395 | 45,724,595 |
| Operating Income | -12,181,494 | -12,181,494 | -3,617,536 | -2,039 | 1,099,598 |
| Net Income | -7,549,619 | -7,549,619 | -4,233,119 | -1,284,172 | 237,704 |
| Cash From Operations | -25,154,333 | -25,154,333 | 251,043 | 14,630,221 | 3,845,307 |
| Capex | n/a | n/a | n/a | n/a | n/a |
| Free Cash Flow | n/a | n/a | n/a | n/a | n/a |
| Cash And Equivalents | 1,172,480 | 1,172,480 | 109,652 | 130,923 | n/a |
| Total Current Assets | 63,697,447 | 63,697,447 | 46,065,964 | 53,310,118 | n/a |
| Total Liabilities | 23,172,520 | 23,172,520 | 60,373,277 | 64,037,936 | n/a |
| Shares Outstanding | 20,500,000 | 20,500,000 | 18,000,000 | 18,000,000 | n/a |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 18,479,452 | 18,479,452 | 18,000,000 | 18,000,000 | 18,000,000 |
| Weighted Avg Shares Basic | 18,479,452 | 18,479,452 | 18,000,000 | 18,000,000 | 18,000,000 |
| Net Share Count Change (Normalized) | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence |
| Ownership Claim Change (Normalized) | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence | Insufficient evidence |
Audit Trail
NCAV Audit
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 63,697,447CNY | derived | 2025-09-30 | 1.00 | n/a |
| Total Liabilities | 23,172,520CNY | derived | 2025-09-30 | 1.00 | n/a |
| Cash | 1,172,480CNY | derived | 2025-09-30 | 1.00 | n/a |
| Shares Outstanding | 20,500,000 | derived | 2025-09-30 | 1.00 | n/a |
| NCAV | 40,524,927CNY | derived | 2025-09-30 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 1.98CNY | derived | 2025-09-30 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Internal NCAV Discount | 46.1% | derived | 2025-09-30 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding
Source Provenance
- Data Source
- Data Vault
- Data Vault Root
- Local evidence | The Data Vault
- CIK
- 0001897532
- Company ID
- n/a
- Selected Annual Source
- Data Vault | sec/companyfacts/cik=0001897532/companyfacts.json
- Selected Quarterly Source
- Data Vault | sec/companyfacts/cik=0001897532/companyfacts.json
- Statement Extractor
- companyfacts-screener-v1
- View Extractor
- companyfacts-screener-v1
- Source Accession Count
- 3
- Imported At
- 2026-08-15T12:52:37+00:00
- Rendered At
- 2026-08-16T03:29:38+00:00
Run Audit
- Mary Run
- 7597e71d9e0c42a48d3fa1ce89682485
- Mary As Of
- 2026-07-11
- Accession
- 0001213900-26-010078
- CIK
- 0001897532
- Mary Filing Date
- 2026-01-30
- Filing Currency
- CNY
- Internal Discount
- 46.1%
- Source State
- Verified
- Market Context
- Not Displayed
- Market Policy
- internal_only_not_redistributed
- Share Trend
- Not Evaluated
- Dilution
- Needs Review
mary_run=7597e71d9e0c42a48d3fa1ce89682485; mary_as_of=2026-07-11; mary_filing_date=2026-01-30; mary_accession=0001213900-26-010078; mary_cik=0001897532; gnni_supporting_filing_date=2026-01-30; internal_discount=0.46057; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.